-
Homoharringtonine Clears SARS-CoV-2: Mechanisms and Implicat
2026-05-30
The referenced study demonstrates that homoharringtonine, a cytotoxic alkaloid, achieves rapid clearance of SARS-CoV-2 from the upper respiratory tract in both preclinical models and early clinical settings. These findings highlight homoharringtonine's translational potential as a targeted protein synthesis inhibitor in future coronavirus epidemic responses.
-
NHE1 in Macrophages Drives Octanal/Olfr2-Induced Atheroscler
2026-05-29
This study demonstrates that sodium-hydrogen exchanger 1 (NHE1) in macrophages acts as a pivotal mediator of octanal/Olfr2-induced atherosclerosis, via calcium-dependent reactive oxygen species (ROS) and NLRP3 inflammasome activation. Targeting NHE1 may provide new therapeutic opportunities for modulating inflammatory pathways in cardiovascular disease.
-
Dynasore: Precision Dynamin GTPase Inhibitor for Vesicle Stu
2026-05-29
Dynasore stands apart as a reversible, non-competitive dynamin GTPase inhibitor, empowering researchers to dissect endocytosis and vesicle trafficking with unmatched accuracy. From colorectal cancer microbiome studies to synaptic vesicle recycling, this APExBIO reagent enables robust, reproducible results and strategic experimental design.
-
EZ Cap™ Cas9 mRNA (m1Ψ): Workflow Optimization in CRISPR Edi
2026-05-28
EZ Cap™ Cas9 mRNA (m1Ψ) empowers researchers to achieve robust, high-specificity CRISPR-Cas9 genome editing in mammalian systems by integrating advanced Cap1 capping and m1Ψ modification. This article delivers actionable guidance on experimental setup, troubleshooting, and leveraging the latest findings in mRNA nuclear export control for maximal editing precision.
-
SIS3 (Smad3 Inhibitor): Transforming Translational Fibrosis
2026-05-28
Explore how SIS3, a potent and selective Smad3 inhibitor, is reshaping the landscape of fibrosis, osteoarthritis, and diabetic nephropathy research. This thought-leadership article delivers mechanistic insight, experimental validation, and actionable strategies for translational researchers, highlighting the clinical relevance and future promise of precise TGF-β/Smad3 pathway modulation.
-
PEG-Lipid Selection Determines LNP mRNA Delivery Performance
2026-05-27
A recent study demonstrates that the acyl chain length of PEG-lipids plays a dominant role in the efficiency of lipid nanoparticle (LNP)–mediated mRNA delivery, both in vitro and in vivo. These findings clarify how minor LNP components can significantly impact transfection outcomes, with implications for mRNA delivery assay design and bioluminescent reporter workflows.
-
ECM Remodeling Drives Mitochondrial Homeostasis via TGF-β Si
2026-05-27
This study uncovers a conserved communication pathway where extracellular matrix (ECM) remodeling—specifically hyaluronan degradation—alters mitochondrial function and immune signaling via TGF-β. The findings provide a mechanistic link between ECM dynamics, mitochondrial fission, and cellular defense, opening new directions for mitochondrial dynamics research and immunometabolic studies.
-
Annexin V-FITC/PI Apoptosis Assay Kit: Practical Protocol Gu
2026-05-26
The Annexin V-FITC/PI Apoptosis Assay Kit enables rapid, discrimination of viable, early apoptotic, and late apoptotic or necrotic cells using fluorescence-based detection. It is ideal for research settings requiring reliable apoptosis quantification via flow cytometry or fluorescence microscopy. The kit should not be used for diagnostic or medical decision-making, and its use is not supported outside of research workflows.
-
Autophagic Degradation of GluN2B Variant NMDA Receptors: Mec
2026-05-26
Benske et al. reveal that a disease-associated GluN2B R519Q variant in NMDA receptors is selectively degraded via the autophagy-lysosomal pathway, rather than by canonical proteasome mechanisms. By dissecting the cellular machinery responsible, this work uncovers new therapeutic targets for neurological disorders linked to NMDAR dysfunction and demonstrates how autophagy and ER-phagy shape receptor proteostasis.
-
D-N-Acetylgalactosamine: Technical Parameters for Brain Glyc
2026-05-25
D-N-Acetylgalactosamine provides a high-purity, water-soluble standard for analyzing glycoprotein constituents and glycosylation pathways in neurological research. It is unsuitable for workflows requiring ethanol solubility or long-term storage of working solutions. Reliable results depend on strict adherence to product-specific handling and storage parameters.
-
Phosphatase Inhibitor Cocktail 2: Precision in Phosphorylati
2026-05-25
Phosphatase Inhibitor Cocktail 2 (100X in ddH2O) from APExBIO delivers robust protein phosphorylation preservation, enabling reproducible signal transduction and proteomics studies. This guide details experimental enhancements, troubleshooting, and advanced applications leveraging its broad-spectrum inhibition.
-
(+)-Bicuculline: Technical Guide for GABAA Receptor Antagoni
2026-05-24
(+)-Bicuculline is a well-established GABAA receptor antagonist used to dissect inhibitory neurotransmission and synaptic NMDA receptor signaling in neuroscience research. It is not suitable for diagnostic or clinical applications and requires strict control of solubility and storage during experimental workflows. Researchers should reference product-specific protocols for optimal performance and reproducibility.
-
(+)-Bicuculline: Technical Guide for Experimental Use
2026-05-23
(+)-Bicuculline is a well-established GABAA receptor antagonist used to investigate inhibitory neurotransmission and synaptic NMDA receptor signaling. It is intended strictly for controlled neuroscience research and is not suitable for diagnostic, clinical, or therapeutic applications. Reliable results require careful attention to solubility, storage, and handling protocols.
-
Lamotrigine in CNS and Cardiac Research: Protocols and Innov
2026-05-22
Lamotrigine’s dual sodium channel blocking and serotonin inhibition powers advanced studies in epilepsy, cardiac sodium current modulation, and blood-brain barrier permeability. Discover stepwise workflows, protocol enhancements, and troubleshooting tactics that elevate CNS and neurocardiac research using high-purity APExBIO Lamotrigine.
-
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Guide
2026-05-22
The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody addresses the need for highly specific and sensitive detection of goat IgG primary antibodies in fluorescence-based assays, including ICC/IF, IHC, flow cytometry, and ELISA. It should not be used with non-goat primary antibodies or outside validated immunodetection workflows due to specificity constraints.